Maria Osama Muhammad, Eliopoulos Nicoletta, Muanza Thierry
Faculty of Medicine, Experimental Medicine Department, McGill University, Montreal, QC, Canada.
Radiation Oncology Department, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Front Oncol. 2017 May 22;7:89. doi: 10.3389/fonc.2017.00089. eCollection 2017.
Radiation-induced oral mucositis (RIOM) is a major dose-limiting toxicity in head and neck cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has marked adverse effects on patient quality of life and cancer therapy continuity. It is a challenge for radiation oncologists since it leads to cancer therapy interruption, poor local tumor control, and changes in dose fractionation. RIOM occurs in 100% of altered fractionation radiotherapy head and neck cancer patients. In the United Sates, its economic cost was estimated to reach 17,000.00 USD per patient with head and neck cancers. This review will discuss RIOM definition, epidemiology, impact and side effects, pathogenesis, scoring scales, diagnosis, differential diagnosis, prevention, and treatment.
Front Oncol. 2017-5-22
J Stomatol Oral Maxillofac Surg. 2025-3
Oncol Lett. 2025-8-8
Int J Oral Sci. 2025-7-15
Cancers (Basel). 2025-7-3
J Cancer Res Clin Oncol. 2025-7-3
Curr Top Med Chem. 2017
Support Care Cancer. 2016-10
Curr Oral Health Rep. 2015
Adv Biomed Res. 2015-2-11